INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $116 | -99.9% | 5,790 | -32.9% | 0.08% | -84.0% |
| Q3 2022 | $186,000 | +431.4% | 8,631 | +374.0% | 0.49% | +420.2% |
| Q2 2022 | $35,000 | -62.8% | 1,821 | -54.8% | 0.09% | +10.6% |
| Q1 2022 | $94,000 | +422.2% | 4,026 | +494.7% | 0.08% | +226.9% |
| Q4 2021 | $18,000 | +38.5% | 677 | +48.5% | 0.03% | +73.3% |
| Q3 2021 | $13,000 | -72.3% | 456 | -72.6% | 0.02% | -68.1% |
| Q2 2021 | $47,000 | +261.5% | 1,667 | +265.6% | 0.05% | +840.0% |
| Q2 2020 | $13,000 | – | 456 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |